Epidemiological markers of Streptococcus pyogenes strains in Tunisia

Clinical Microbiology and Infection

Volumn 17, Issue 1, 2011, Pages 63-68

  Hraoui, M ^a   Boutiba Ben Boubaker, I ^a   Doloy, A ^b   Samir, E ^a   Ben Redjeb, S ^a   Bouvet, A ^b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b Service de Microbiologie HygièneHôtel Dieu Assistance Publique   (France)

Author keywords

emm typing; Streptococcus pyogenes; T typing; Toxin profiles

Indexed keywords

AMOXICILLIN; BACITRACIN; BACTERIAL TOXIN; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; MACROLIDE; MIKAMYCIN B; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRITIS; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOTYPE; CELLULITIS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; EMM GENE; ENDOCARDITIS; ENDOMETRITIS; EPIDEMIOLOGICAL DATA; ERYSIPELAS; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); GROUP A STREPTOCOCCAL INFECTION; HUMAN; IMPETIGO; LYMPHADENITIS; MAJOR CLINICAL STUDY; MENINGITIS; NONHUMAN; OSTEITIS; PERITONITIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; SKIN INFECTION; SOFT TISSUE INFECTION; SPEA GENE; SPEB GENE; SPEC GENE; STREPTOCOCCUS PYOGENES; SURGICAL INFECTION; TONSILLITIS; TUNISIA; URINARY TRACT INFECTION; VAGINITIS; WOUND INFECTION;

SPEA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 78650099662     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03174.x     Document Type: Article

References (30)

1. Bisno AL, Berrios X. Cessation of rheumatic fever prophylaxis in young adults. Trans Assoc Am Physicians 1991; 104: 125-130.
2. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45: 3-12.
3. Chatellier S, Ihendyane N, Kansal RG. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and non-rsevere invasive diseases. Infect Immun 2000; 68: 3523-3534.
4. O'Loughlin RE, Roberson A, Cieslak PR et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45: 853-862.
5. Centers for Disease Control and Prevention. 2006. CDC emm sequence database. Available at: (last accessed 4 June 2006).
6. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29: 1562-1567.
7. Alba R, Montserrat R, Elisenda M et al. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 2006; 55: 1115-1123.
8. Seppälä H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-891.
9. Bouvet A, Geslin P, Kriz-Kuzemenska P, Blanc V, Devine C, Grimont F. Restricted association between biotypes and serotypes within group A streptococci. J Clin Microbiol 1994; 32: 1312-1317.
10. Johnson DR, Kaplan EL, Sramek J et al. Determination of T-protein agglutination patterns. In: Johnson DR, ed. Laboratory diagnosis of group A streptococcal infections. Geneva: World Health Organization, 1996; 37-41.
11. McNeil SA, Halperin SA, Langley JM. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41: 1123-1124.
12. Creti R, Imperi M, Baldassarri L et al. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 2007; 45: 2249-2256.
13. Jing H, Ning B, Hao H et al. Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol 2006; 55: 1101-1107.
14. Musser JM, Kapur V, Kanjilal S. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis 1993; 167: 337-346.
15. Kaul RA, McGeer A, Low DE, Green K, Schwartz B, Simor AE. Population-based surveillance for group A streptococcal necrotizing fasciitis, clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med 1997; 103: 18-24.
16. Mihaila-Amrouche L, Bouvet A, Loubinoux J. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol 2004; 42: 3844-3846.
17. Siljander T, Toropainen M, Muotiala A, Hoe NP, Musser JM, Vuopo-Varkila J. emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J Med Microbiol 2006; 55: 1701-1706.
18. Watanabe Y, Todome Y, Ohkuni H et al. Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect Immun 2002; 70: 3944-3947.
19. Cole JN, McArthur JD, McKay FC et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J 2006; 20: 1745-1747.
20. Mzoughi R, Bouallegue O, Selmi H, Ben Said H, Essoussi AS, Jeddi M. Group A streptococci in children with acute pharyngitis in Sousse, Tunisia. East Mediterr Health J 2004; 10: 488-493.
21. Johnson DR, Kaplan EL, VanGheem A, Facklam RR, Beall B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol 2005; 55: 157-164.
22. Lopardo HA, Venuta ME, Vidal P et al. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. Diagn Microbiol Infect Dis 1997; 29: 29-32.
23. Jasir A, Schalen C. Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. J Antimicrobiol Chemother 1998; 41: 135-137.
24. Kataja J, Huovinen P, Muotiala A et al. Clonal spread of group A Streptococcus with the new type of erythromycin resistance. J Infect Dis 1998; 177: 786-789.
25. Bassetti M, Manno G, Collida A et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000; 6: 180-183.
26. Kim S, Lee NY. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea. J Antimicrobiol Chemother 2004; 54: 447-450.
27. De Melo MC, Sa Figueredo AM, Teixeira B. Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978-1997 in different Brazilian cities. J Med Microbiol 2003; 52: 251-258.
28. Jasir A, Tanna A, Noorani A, Mirsalehian A, Efstratiou A, Schalen C. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J Clin Microbiol 2000; 38: 2103-2107.
29. Nielsen HU, Kolmos HJ, Frimodt-Moller N. Beta-hemolytic streptococcal bacteraemia: a review of 241 cases. Scand J Infect Dis 2002; 34: 483-486.
30. Gattringe R, Sauermann R, Lagler H et al. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Int J Antimicrob Agents 2004; 24: 92-95.